Earnings results expected in 43 days
Summary
ABL closed today lower at €116.24, a decrease of 0.39% from yesterday's close, completing a monthly increase of 0.82% or €0.94. Over the past 12 months, ABL stock gained 6.37%.
ABL pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next estimated payment will be in In 2 months on Aug 15, 2025 for a total of €0.59.
The last earnings report, released on Apr 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
The stock of the company had never split.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABL Chart
Loading, please wait...
Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds
ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook.
Zacks | 4 days ago
Abbott (ABT) Rises Higher Than Market: Key Facts
Abbott (ABT) closed the most recent trading day at $132.85, moving +0.63% from the previous trading session.
Zacks | 4 days ago
Abbott Stock Gains Following FDA Approval of the Tendyne System
ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.
Zacks | 6 days ago
Abbott Laboratories Dividends
 ABL 7 months ago | Other | €0.55 Per Share |
| ABL 10 months ago | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
| ABL 12 Oct 2023 | Other | €0.51 Per Share |
Abbott Laboratories Earnings
| 16 Jul 2025 (43 Days) Date | | - Cons. EPS | - EPS |
| 16 Apr 2025 Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | - Cons. EPS | - EPS |
| 16 Oct 2024 Date | | - Cons. EPS | - EPS |
| ABL 7 months ago | Other | €0.55 Per Share |
| ABL 10 months ago | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
| ABL 12 Oct 2023 | Other | €0.51 Per Share |
| 16 Jul 2025 (43 Days) Date | | - Cons. EPS | - EPS |
| 16 Apr 2025 Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | - Cons. EPS | - EPS |
| 16 Oct 2024 Date | | - Cons. EPS | - EPS |
Abbott Laboratories (ABL) FAQ
What is the stock price today?
The current price is €116.24.
On which exchange is it traded?
Abbott Laboratories is listed on NYSE.
What is its stock symbol?
The ticker symbol is ABL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Jul 16, 2025.
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories had 0 splits and the recent split was on Jan 02, 2013.
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | XBER Exchange | US0028241000 ISIN |
| US Country | 114,000 Employees | 15 Apr 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
